In the days leading up to the U.S. Food and Drug Administration’s approval of Pfizer’s COVID-19 vaccine, U.S. and U.K. health officials entered into a “mutual confidentiality agreement” to keep vaccine adverse events under wraps.
- U.S. and U.K. health officials discussed “anaphylactoid reactions” due to COVID-19 shots and emphasized their “mutual confidentiality agreement” regarding the topic.
- The news was revealed in 57 pages of heavily redacted U.S. Department of Health and Human Services (HHS) records via a Freedom of Information Act (FOIA) lawsuit.
- A government email exchange from May 14, 2021, also discusses concerns about administering COVID-19 shots along with other vaccines during pregnancy
- Regulatory filings show Pfizer knew of its shots’ waning effectiveness in April 2021 but didn’t publicly acknowledge it until late July 2021.
- Preclinical studies for Pfizer’s COVID-19 shots also warned of rhabdomyolysis, which is the breakdown of skeletal muscles, but the trial reported it was “completed with no safety concerns.”